Skip to main content
. Author manuscript; available in PMC: 2015 Oct 2.
Published in final edited form as: J Clin Virol. 2013 Jul 6;58(1):240–244. doi: 10.1016/j.jcv.2013.06.019

Table 2.

HIV rapid test results among specimens with repeatedly reactive HIV 1/2 IA, negative or indeterminate Western blot, and negative APTIMA results

Rapid HIV test Indeterminate WB, negative APTIMA (n=735) and positive RT N (%) Negative WB, negative APTIMA (n=2343) and positive RT N (%) Total with positive RT and negative APTIMA (n=3078) Proportion with negative APTIMA and negative RT (95% Confidence Interval)
Clearview 23 (3.1%) 10 (0.4%) 33 98.9% (98.5%–99.3%)
Multispot 37 (5.0%) 26 (1.1%) 63 98.0% (97.4%–98.4%)
Oraquick 26 (3.5%) 10 (0.4%) 36 98.8% (98.4%–99.2%)
Reveal 16 (2.2%) 14 (0.6%) 30 99.0%a (98.6%–99.3%)
Unigold 29 (4.0%) 9 (0.4%) 38 98.8% (98.3%–99.1%)
>1 reactive rapid test 33 (4.5%) 11 (0.5%) n/a not applicable

WB=Western blot; RT=Rapid test

a

7 specimens had invalid results with Reveal, and were not included in analyses.